← All trials
NCT02071680
Phase 3Interventional
Includes trials conducted after preliminary evidence suggesting effectiveness of the drug has been obtained, and are intended to gather additional information to evaluate the overall benefit-risk relationship of the drug.
View on ClinicalTrials.gov ↗Timeline
- Start date
- Mar 31, 2015
- Primary completion
- Aug 31, 2015
- Completion date
- Aug 31, 2015
- First posted
- Feb 26, 2014
- Last posted
- Dec 22, 2016
- Enrollment
- 5
- Arms / groups
- 1 / —
- Source
- AACT · ctgov ingestion
Sponsors
- University of OttawaLead sponsor
- University of OttawaOverall official - principal investigator
- University of OttawaReponsible party - principal investigator
Drugs studied
Indications studied
CDEK-curated fields only — the ClinicalTrials.gov results mirror (baseline measures, adverse events, participant flow) is a separate, currently-dormant pipeline; see MIGRATION_PLAN.md.